Andrew S. Herbert

7.3k total citations · 2 hit papers
29 papers, 2.9k citations indexed

About

Andrew S. Herbert is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Andrew S. Herbert has authored 29 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Andrew S. Herbert's work include Viral Infections and Outbreaks Research (24 papers), Viral Infections and Vectors (19 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Andrew S. Herbert is often cited by papers focused on Viral Infections and Outbreaks Research (24 papers), Viral Infections and Vectors (19 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Andrew S. Herbert collaborates with scholars based in United States, Netherlands and Uganda. Andrew S. Herbert's co-authors include John M. Dye, Ana I. Kuehne, Sean P. J. Whelan, Thijn R. Brummelkamp, Kartik Chandran, Matthijs Raaben, Jan E. Carette, Gregor Obernosterer, Gordon Ruthel and April M. Griffin and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Andrew S. Herbert

29 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ebola virus entry requires the cholesterol transporter Niemann–Pick C1

2011 972 citations Jan E. Carette, Matthijs Raaben et al. Nature profile →
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

2020 389 citations Kui K. Chan, Danielle E. Dorosky et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew S. Herbert United States	21	2.0k	786	693	311	310	29	2.9k
Ana I. Kuehne United States	20	1.9k 0.9×	850 1.1×	502 0.7×	307 1.0×	282 0.9×	35	2.7k
Kathryn L. Schornberg United States	12	1.4k 0.7×	757 1.0×	388 0.6×	233 0.7×	215 0.7×	13	2.0k
Matthijs Raaben Netherlands	22	1.5k 0.7×	677 0.9×	993 1.4×	299 1.0×	439 1.4×	28	2.9k
Hans-Dieter Klenk Germany	15	1.6k 0.8×	1.2k 1.6×	495 0.7×	113 0.4×	233 0.8×	17	2.6k
Alexander N. Freiberg United States	34	2.4k 1.2×	1.3k 1.6×	813 1.2×	628 2.0×	292 0.9×	110	4.0k
Andrey A. Kolokoltsov United States	21	1.2k 0.6×	644 0.8×	449 0.6×	328 1.1×	179 0.6×	32	2.1k
Masahiro Niikura Japan	27	691 0.3×	997 1.3×	400 0.6×	143 0.5×	186 0.6×	88	2.0k
Martti T. Tammi Singapore	18	915 0.4×	1.1k 1.4×	782 1.1×	89 0.3×	494 1.6×	33	2.5k
Balaji Manicassamy United States	35	1.0k 0.5×	2.3k 2.9×	1.4k 2.0×	138 0.4×	242 0.8×	64	4.0k
Manuel Rosa‐Calatrava France	31	996 0.5×	1.0k 1.3×	1.1k 1.5×	70 0.2×	417 1.3×	87	2.6k

Countries citing papers authored by Andrew S. Herbert

Since Specialization

Citations

This map shows the geographic impact of Andrew S. Herbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew S. Herbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew S. Herbert more than expected).

Fields of papers citing papers by Andrew S. Herbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew S. Herbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew S. Herbert. The network helps show where Andrew S. Herbert may publish in the future.

Co-authorship network of co-authors of Andrew S. Herbert

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew S. Herbert. A scholar is included among the top collaborators of Andrew S. Herbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew S. Herbert. Andrew S. Herbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuehne, Ana I., et al.. (2024). Engineering and structures of Crimean-Congo hemorrhagic fever virus glycoprotein complexes. Cell. 188(2). 303–315.e13. 1 indexed citations

Gupta, Yash, Samantha E. Zak, Chandrashekhar V. Kulkarni, et al.. (2021). Heparin: A simplistic repurposing to prevent SARS-CoV-2 transmission in light of its in-vitro nanomolar efficacy. International Journal of Biological Macromolecules. 183. 203–212. 25 indexed citations

Gupta, Yash, Samantha E. Zak, Krysten A. Jones, et al.. (2021). Bisindolylmaleimide IX: A novel anti-SARS-CoV2 agent targeting viral main protease 3CLpro demonstrated by virtual screening pipeline and in-vitro validation assays. Methods. 195. 57–71. 27 indexed citations

Gupta, Yash, Sumit Kumar, Samantha E. Zak, et al.. (2021). Antiviral evaluation of hydroxyethylamine analogs: Inhibitors of SARS-CoV-2 main protease (3CLpro), a virtual screening and simulation approach. Bioorganic & Medicinal Chemistry. 47. 116393–116393. 15 indexed citations

Chan, Kui K., Danielle E. Dorosky, Preeti Sharma, et al.. (2020). Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2. Science. 369(6508). 1261–1265. 389 indexed citations breakdown →

Wec, Anna Z., Crystal L. Moyer, Marnie L. Fusco, et al.. (2019). Structural basis of broad ebolavirus neutralization by a human survivor antibody. Nature Structural & Molecular Biology. 26(3). 204–212. 25 indexed citations

Sobarzo, Ariel, Spencer W. Stonier, Sigal Gelkop, et al.. (2019). Multiple viral proteins and immune response pathways act to generate robust long-term immunity in Sudan virus survivors. EBioMedicine. 46. 215–226. 2 indexed citations

Froude, Jeffrey W., Andrew S. Herbert, Thibaut Pelat, et al.. (2018). Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail. Viruses. 10(6). 286–286. 16 indexed citations

Stonier, Spencer W., Andrew S. Herbert, Ana I. Kuehne, et al.. (2017). Marburg virus survivor immune responses are Th1 skewed with limited neutralizing antibody responses. The Journal of Experimental Medicine. 214(9). 2563–2572. 19 indexed citations

10.

Raaben, Matthijs, Lucas T. Jae, Andrew S. Herbert, et al.. (2017). NRP2 and CD63 Are Host Factors for Lujo Virus Cell Entry. Cell Host & Microbe. 22(5). 688–696.e5. 91 indexed citations

11.

Howell, Katie A., Jennifer M. Brannan, Christopher Bryan, et al.. (2017). Cooperativity Enables Non-neutralizing Antibodies to Neutralize Ebolavirus. Cell Reports. 19(2). 413–424. 53 indexed citations

12.

Kash, John C., Kathie‐Anne Walters, Jason Kindrachuk, et al.. (2017). Longitudinal peripheral blood transcriptional analysis of a patient with severe Ebola virus disease. Science Translational Medicine. 9(385). 23 indexed citations

13.

Lennemann, Nicholas J., Andrew S. Herbert, Rachel B. Brouillette, et al.. (2017). Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice. Journal of Virology. 91(17). 22 indexed citations

14.

Wec, Anna Z., Elisabeth K. Nyakatura, Andrew S. Herbert, et al.. (2016). A “Trojan horse” bispecific-antibody strategy for broad protection against ebolaviruses. Science. 354(6310). 350–354. 80 indexed citations

15.

Sobarzo, Ariel, Spencer W. Stonier, Andrew S. Herbert, et al.. (2016). Correspondence of Neutralizing Humoral Immunity and CD4 T Cell Responses in Long Recovered Sudan Virus Survivors. Viruses. 8(5). 133–133. 7 indexed citations

16.

Sobarzo, Ariel, Andrew S. Herbert, Ana I. Kuehne, et al.. (2015). Immune Memory to Sudan Virus: Comparison between Two Separate Disease Outbreaks. Viruses. 7(1). 37–51. 17 indexed citations

17.

Basu, Arnab, Debra M. Mills, Daniel A. Mitchell, et al.. (2015). Novel Small Molecule Entry Inhibitors of Ebola Virus. The Journal of Infectious Diseases. 212(suppl 2). S425–S434. 44 indexed citations

18.

Herbert, Andrew S., Ana I. Kuehne, James F. Barth, et al.. (2013). Venezuelan Equine Encephalitis Virus Replicon Particle Vaccine Protects Nonhuman Primates from Intramuscular and Aerosol Challenge with Ebolavirus. Journal of Virology. 87(9). 4952–4964. 85 indexed citations

19.

Miller, Emily Happy, Gregor Obernosterer, Matthijs Raaben, et al.. (2012). Ebola virus entry requires the host‐programmed recognition of an intracellular receptor. The EMBO Journal. 31(8). 1947–1960. 253 indexed citations

20.

Carette, Jan E., Matthijs Raaben, Anthony Wong, et al.. (2011). Ebola virus entry requires the cholesterol transporter Niemann–Pick C1. Nature. 477(7364). 340–343. 972 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact